Proteomics International Laboratories Ltd

Research Proteomics International Laboratories Ltd (PIQ) on Bullrun: market cap AUD 18.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPIQ
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 18.17M
• Financial periodFY2025
• RevenueAUD 960.39K
• Revenue growth7.6%
• Net income-AUD 8.11M
• Free cash flow-AUD 6.63M
• Gross margin100.0%

Valuation Snapshot

latest market cap is AUD 18.17M.

About Proteomics International Laboratories Ltd

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company's products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis;

Frequently asked questions

What is Proteomics International Laboratories Ltd's market cap?

Proteomics International Laboratories Ltd's market capitalization is AUD 18.17M.

What does Proteomics International Laboratories Ltd do?

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD).